PBA functionalized single-atom Fe for efficient therapy of multidrug-resistant bacterial infections

Colloids Surf B Biointerfaces. 2022 Nov:219:112811. doi: 10.1016/j.colsurfb.2022.112811. Epub 2022 Aug 28.

Abstract

The abuse of antibiotics has led to the emergence of multidrug-resistant bacterial strains worldwide, which greatly threatens human health. In the present work, we developed single-atom catalysts (SACs) with atomically dispersed Fe as catalytic sites (Fe-SACs) to combat multidrug-resistant bacteria by elevating cellular reactive oxygen species (ROS). Our intensive studies confirmed that Fe-SACs were successfully prepared and exhibited excellent catalase (CAT)-, oxidase (OXD)-, and peroxidase (POD)-like activities. To enhance water dispersibility, biosafety and the interactions between the nanodrugs and gram-positive bacteria, phenylboronic acid group-functionalized carboxylated chitosan (CCS-PBA) was coated on the surface of Fe-SACs to yield Fe-SACs@CCS-PBA for in vitro and in vivo studies. The synergistic catalytic activity and photothermal activity of Fe-SACs@CCS-PBA effectively overcame multidrug-resistant bacterial strains (MRSA) in vitro and significantly accelerated wound healing in vivo, suggesting the great potential of SACs to overcome infectious disease caused by multidrug-resistant bacteria.

Keywords: Antimultidrug-resistant bacteria; Catalytic therapy; Photothermal therapy; Single-atom catalysts.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Infections*
  • Carboxylic Acids
  • Chitosan*
  • Humans
  • Reactive Oxygen Species

Substances

  • Anti-Bacterial Agents
  • Carboxylic Acids
  • Chitosan
  • Reactive Oxygen Species